Chapter 13: Guided Lecture Notes
· Chapter Overview
o Question about the ANS (PowerPoint Slides 2 and 3; Learning Objective 1)
o Provide an overview of the chapter (PowerPoint Slide 4; Learning Objective 1)
· Physiology
o Discuss the function of the autonomic nervous system (PowerPoint Slide 5; Learning Objectives 1 and 2)
o Discuss the effects of the SNS and the PSNS on the body (PowerPoint Slide 6; Learning Objectives 1 and 2, figure 13.2)
· Adrenergic Receptors
o Provide an overview of adrenergic receptors (PowerPoint Slide 7; Learning Objective 1)
· Pathophysiology
o Provide an overview of the conditions treated with these agents, which stimulate and block adrenergic stimulation (PowerPoint Slide 8; Learning Objective 1)
· Nursing Management of the Patient Receiving Epinephrine
o Provide and overview of adrenergic agonists (PowerPoint Slide 9; Learning Objective 3)
o Discuss the core drug knowledge related to epinephrine (PowerPoint Slides 10 and 11; Learning Objectives 3 and 4)
§ Pharmacotherapeutics
§ Pharmacokinetics
§ Pharmacodynamics
§ Contraindications and precautions
§ Adverse effects
§ Drug interactions
o Discuss the core patient variables related to epinephrine (PowerPoint Slide 12; Learning Objectives 5 and 6)
§ Health status
§ Life span and gender
§ Lifestyle, diet, and habits
§ Environment
o Discuss the nursing diagnoses and outcomes related to epinephrine (PowerPoint Slide 13; Learning Objective 7)
o Discuss the planning and interventions related to epinephrine (PowerPoint Slide 14; Learning Objective 8)
§ Interventions to maximize therapeutic effects
§ Intervention to minimize adverse effects
o Discuss the teaching, assessment, and evaluation related to epinephrine (PowerPoint Slide 15; Learning Objective 9)
§ Patient and family education
§ Ongoing assessment and evaluation
o Question about epinephrine (PowerPoint Slides 16 and 17; Learning Objective 4)
· Nursing Management of the Patient Receiving Phenylephrine
o Provide an overview of alpha-1 adrenergic agonists (PowerPoint Slide 18; Learning Objective 3)
o Discuss the core drug knowledge related to phenylephrine (PowerPoint Slides 19 and 20; Learning Objectives 3 and 4)
§ Pharmacotherapeutics
§ Pharmacokinetics
§ Pharmacodynamics
§ Contraindications and precautions
§ Adverse effects
§ Drug interactions
o Discuss the core patient variables related to phenylephrine (PowerPoint Slide 21; Learning Objectives 5 and 6)
§ Health status
§ Life span and gender
§ Lifestyle, diet, and habits
§ Environment
o Discuss the nursing diagnoses and outcomes related to phenylephrine (PowerPoint Slide 22; Learning Objective 7)
o Discuss the planning and interventions related to phenylephrine (PowerPoint Slide 23; Learning Objective 8)
§ Interventions to maximize therapeutic effects
§ Intervention to minimize adverse effects
o Discuss the teaching, assessment, and evaluation related to phenylephrine (PowerPoint Slide 24; Learning Objective 9)
§ Patient and family education
§ Ongoing assessment and evaluation
· Nursing Management of the Patient Receiving Dopamine
o Provide an overview of alpha-2 adrenergic agonists and beta-adrenergic agonists (PowerPoint Slide 25; Learning Objective 3)
o Discuss the core drug knowledge related to dopamine (PowerPoint Slides 26, 27, and 28; Learning Objectives 3 and 4, table 13.6)
§ Pharmacotherapeutics
§ Pharmacokinetics
§ Pharmacodynamics
§ Contraindications and precautions
§ Adverse effects
§ Drug interactions
o Discuss the core patient variables related to dopamine (PowerPoint Slide 29; Learning Objectives 5 and 6)
§ Health status
§ Life span and gender
§ Environment
o Discuss the nursing diagnoses and outcomes related to dopamine (PowerPoint Slide 30; Learning Objective 7)
o Discuss the planning and interventions related to dopamine (PowerPoint Slide 31; Learning Objective 8)
§ Interventions to maximize therapeutic effects
§ Intervention to minimize adverse effects
o Discuss the teaching, assessment, and evaluation related to dopamine (PowerPoint Slide 32; Learning Objective 9)
§ Patient and family education
§ Ongoing assessment and evaluation
o Question about dopamine administration (PowerPoint Slides 33 and 34; Learning Objectives 3, 4 and 5)
· Nursing Management of the Patient Receiving Fenoldopam
o Provide an overview of dopaminergic agonist agents (PowerPoint Slide 35; Learning Objective 3)
o Discuss the core drug knowledge related to fenoldopam (PowerPoint Slides 36 and 37; Learning Objectives 3 and 4)
§ Pharmacotherapeutics
§ Pharmacokinetics
§ Pharmacodynamics
§ Contraindications and precautions
§ Adverse effects
§ Drug interactions
o Discuss the core patient variables related to fenoldopam (PowerPoint Slide 38; Learning Objectives 5 and 6)
§ Health status
§ Life span and gender
§ Environment
o Discuss the nursing diagnoses and outcomes related to fenoldopam (PowerPoint Slide 39; Learning Objective 7)
o Discuss the planning and interventions related to fenoldopam (PowerPoint Slide 40; Learning Objective 8)
§ Interventions to maximize therapeutic effects
§ Intervention to minimize adverse effects
o Discuss the teaching, assessment, and evaluation related to fenoldopam (PowerPoint Slide 41; Learning Objective 9)
§ Patient and family education
§ Ongoing assessment and evaluation
· Nursing Management of the Patient Receiving Prazosin
o Provide an overview of alpha-adrenergic antagonists (PowerPoint Slide 42; Learning Objective 3)
o Discuss the core drug knowledge related to prazosin (PowerPoint Slides 43 and 44; Learning Objectives 3 and 4)
§ Pharmacotherapeutics
§ Pharmacokinetics
§ Pharmacodynamics
§ Contraindications and precautions
§ Adverse effects
§ Drug interactions
o Discuss the core patient variables related to prazosin (PowerPoint Slide 45; Learning Objectives 5 and 6)
§ Health status
§ Life span and gender
§ Lifestyle, diet, and habits
§ Environment
o Discuss the nursing diagnoses and outcomes related to prazosin (PowerPoint Slide 46; Learning Objective 7)
o Discuss the planning and interventions related to prazosin (PowerPoint Slide 47; Learning Objective 8)
§ Interventions to maximize therapeutic effects
§ Intervention to minimize adverse effects
o Discuss the teaching, assessment, and evaluation related to Prazosin (PowerPoint Slide 48; Learning Objective 9)
§ Patient and family education
§ Ongoing assessment and evaluation
· Nursing Management of the Patient Receiving Metoprolol
o Provide an overview of beta-adrenergic antagonists (PowerPoint Slide 49; Learning Objective 3)
o Discuss the core drug knowledge related to metoprolol (PowerPoint Slides 50 and 51; Learning Objectives 3 and 4)
§ Pharmacotherapeutics
§ Pharmacokinetics
§ Pharmacodynamics
§ Contraindications and precautions
§ Adverse effects
§ Drug interactions
o Discuss the core patient variables related to metoprolol (PowerPoint Slide 52; Learning Objectives 5 and 6)
§ Health status
§ Life span and gender
§ Lifestyle, diet, and habits
§ Environment
o Discuss the nursing diagnoses and outcomes related to metoprolol (PowerPoint Slide 53; Learning Objective 7)
o Discuss the planning and interventions related to metoprolol (PowerPoint Slide 54; Learning Objective 8)
§ Interventions to maximize therapeutic effects
§ Intervention to minimize adverse effects
o Discuss the teaching, assessment, and evaluation related to metoprolol (PowerPoint Slide 55; Learning Objective 9)
§ Patient and family education
§ Ongoing assessment and evaluation